Elkridge, MDNCT07147647Now EnrollingIRB Ready

Primary Open Angle Glaucoma (POAG) Clinical Trial in Elkridge, MD

Access cutting-edge primary open angle glaucoma (poag) treatment through this clinical trial at a research site in Elkridge. Study-provided care at no cost to qualified participants.

Sponsored by Select Eye Care

Quick Self-Assessment

See if you qualify for this Elkridge location

Preparing your pre-screening questions…

Expert Care in Elkridge

Access primary open angle glaucoma (poag) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary open angle glaucoma (poag) treatment provided free

Apply for This Elkridge Location

Check if you qualify for this primary open angle glaucoma (poag) clinical trial in Elkridge, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Elkridge

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Elkridge site if eligible
  4. 4Begin participation

About This Primary Open Angle Glaucoma (POAG) Study in Elkridge

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.

Sponsor: Select Eye Care

Who Can Participate

Inclusion Criteria

Adult patients of Black African descent scheduled to undergo DSLT treatment in one or both eyes.
Diagnosis of mild to moderate primary open angle glaucoma (POAG).
Mild to moderate POAG will be defined as Stage 2 or better of the Hodapp-Anderson-Parrish glaucoma staging system.
Treatment naive or washed out IOP at time 0 ranging from ≥ 21 through 32 mm Hg.

Exclusion Criteria

Screened patients who were on IOP-lowering medications who did not successfully complete medication washout at the time of the procedure (time 0).
Previous glaucoma surgeries/interventions:
Patients who have undergone prior glaucoma-related procedures (e.g., trabeculectomy, laser trabeculoplasty, MIGS, or tube shunt).
Secondary glaucoma:
Patients with secondary forms of glaucoma, such as angle-closure glaucoma, neovascular glaucoma, or glaucoma resulting from trauma or other systemic diseases.
Other significant ocular conditions including advanced cataracts, retinal diseases (e.g., age-related macular degeneration), or any condition that might complicate the assessment of intraocular pressure (IOP) or visual function as deemed by the investigator.
Subjects who are pregnant, breast-feeding, or intend to become pregnant during the study period as determined by verbal inquiry.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Elkridge?

Yes, this clinical trial (NCT07147647) has an active research site in Elkridge, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Open Angle Glaucoma (POAG) Treatment Options in Elkridge, MD

If you're searching for primary open angle glaucoma (poag) treatment options in Elkridge, MD, this clinical trial (NCT07147647) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Elkridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary open angle glaucoma (poag) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary open angle glaucoma (poag) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Elkridge, MD

See all pulmonary embolism clinical trials recruiting in Elkridge — not just this study.

Browse Pulmonary Embolism Trials in Elkridge →

Browse More Trials by Condition

Pulmonary Embolism TrialsUlcerative Colitis TrialsGlaucoma TrialsOsteoarthritis TrialsAll Conditions →

Ready to Join in Elkridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Elkridge, MD